home / stock / sgiof / sgiof news


SGIOF News and Press, Shionogi & Co Ltd

Stock Information

Company Name: Shionogi & Co Ltd
Stock Symbol: SGIOF
Market: OTC

Menu

SGIOF SGIOF Quote SGIOF Short SGIOF News SGIOF Articles SGIOF Message Board
Get SGIOF Alerts

News, Short Squeeze, Breakout and More Instantly...

SGIOF - Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare

2024-06-17 10:40:00 ET Summary Shionogi optioned rights for two candidates targeting cochlear synaptopathy, including one that is poised to start a Phase II trial. XtalPi raised US$126.8 million in a Hong Kong IPO, the third-largest Hong Kong IPO of the year. Takeda entered a ...

SGIOF - Diamond Hill International Fund Q1 2024 Market Commentary

2024-05-16 01:01:00 ET Summary Diamond Hill invests on behalf of clients through a shared commitment to its valuation-driven investment principles, long-term perspective, capacity discipline and client alignment. Markets were mostly positive in Q1 2024, with the ongoing notable ex...

SGIOF - ViiV's long-acting HIV therapy outperforms daily therapy in Phase 3 trial

2024-03-06 14:31:39 ET More on GSK GSK Plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy GSK plc (GSK) Q4 2023 Earnings Call Transcript GSK plc 2023 Q4 - Results - Earnings Call Presentation Guggenheim upgrades GSK to buy from neutral ...

SGIOF - Shionogi & Co., Ltd. (SGIOF) Q2 2023 Earnings Conference Call Transcript

2023-11-01 07:06:02 ET Shionogi & Co., Ltd. (SGIOF) Q2 2023 Earnings Conference Call October 31, 2023, 09:30 PM ET Company Participants Yoshimasa Kyokawa - VP, Corporate Communications Isao Teshirogi - Representative Director, President and CEO Toshinobu Iwas...

SGIOF - GSK unit ViiV raises outlook on long-term HIV therapies

2023-09-29 07:16:33 ET More on GSK Merck Vs. GSK: The Game-Changer Race In Pharma Excellence GSK plc (GSK) BofA Global Healthcare Conference (Transcript) GSK plc (GSK) Citi's 18th Annual BioPharma Conference Transcript Wave Life Sciences spikes on R&D Day...

SGIOF - Viatris wins tentative FDA approval for HIV therapy in children

2023-09-05 06:42:18 ET More on Viatris Seeking Alpha’s Quant Rating on Viatris Historical earnings data for Viatris Dividend scorecard for Viatris Financial information for Viatris Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs M...

SGIOF - Daiichi COVID vaccine endorsed in Japan; Shionogi's shot declined

2023-08-01 13:32:44 ET More on Daiichi Sankyo Daiichi Sankyo Company, Limited ( OTCPK:DSKYF ) Q1 2023 Earnings Call Transcript Shionogi & Co., Ltd. ( OTCPK:SGIOF ) Q1 2023 Earnings Call Transcript Daiichi Sankyo: There Is A Lot Of Room To Grow Dai...

SGIOF - Shionogi & Co. GAAP EPS of ¥144.57, revenue of ¥109.31B

2023-07-31 15:48:40 ET Shionogi & Co. press release ( OTCPK:SGIOF ): Q1 GAAP EPS of ¥144.57. Revenue of ¥109.31B (+52.2% Y/Y). For further details see: Shionogi & Co. GAAP EPS of ¥144.57, revenue of ¥109.31B

SGIOF - Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript

2023-05-14 22:31:09 ET Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Conference Call May 10, 2023, 10:00 PM ET Company Participants Yoshimasa Kyokawa - Investor Relations Isao Teshirogi - Chairman and CEO John Keller - Executive Officer, the General Manager o...

SGIOF - Shionogi & Co. GAAP EPS of ¥621.31, revenue of ¥426.7B

2023-05-11 12:44:17 ET Shionogi & Co. ( OTCPK:SGIOF ): FY GAAP EPS of ¥621.31. Revenue of ¥426.7B For further details see: Shionogi & Co. GAAP EPS of ¥621.31, revenue of ¥426.7B

Next 10